Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NOVO NORDISK INC. via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| CARMAX |
| 5 |
| 2009–2010 |
| DES MOINES UNIVERSITY | 4 | 2011 |
| NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS | 4 | 2012 |
| PLASMA PROTEIN THERAPEUTICS ASSOCIATION | 4 | 2014 |
| FRESENIUS MEDICAL CARE | 3 | 2013–2014 |
| MARATHON ASSET MANAGEMENT INC | 2 | 2009 |
| INSTITUTIONAL CREDIT PARTNERS | 1 | 2009 |
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
H.R. 15/S. 744, Border Security, Economic Opportunity, and Immigration Modernization Act. H.R. 1772, Legal Workforce Act.
H.R. 15/S. 744, Border Security, Economic Opportunity, and Immigration Modernization Act. H.R. 1772, Legal Workforce Act.
Preserving Access to Orphan Drugs Act of 2013
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: DLA PIPER LLP (US)
Orphan exemption to the annual pharmaceutical fee; Orphan drug tax credit; Patient access to therapies; H.R. 2315/S. 1128, Preserving Access to Orphan Drugs Act; H.R. 460, Patients Access to Treatments Act; H.R. 3116, Modernizing Our Drug and Diagnostics Evaluation and Regulatory Network Cures Act.
MODDERN Cures Act of 2013
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: DLA PIPER LLP (US)
Orphan exemption to the annual pharmaceutical fee; Orphan drug tax credit; Patient access to therapies; H.R. 2315/S. 1128, Preserving Access to Orphan Drugs Act; H.R. 460, Patients Access to Treatments Act; H.R. 3116, Modernizing Our Drug and Diagnostics Evaluation and Regulatory Network Cures Act.
Patients' Access to Treatments Act of 2013
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: DLA PIPER LLP (US)
Orphan exemption to the annual pharmaceutical fee; Orphan drug tax credit; Patient access to therapies; H.R. 2315/S. 1128, Preserving Access to Orphan Drugs Act; H.R. 460, Patients Access to Treatments Act; H.R. 3116, Modernizing Our Drug and Diagnostics Evaluation and Regulatory Network Cures Act.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Supporting the goals and ideals of the MAGIC Foundation.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Supporting the goals and ideals of the MAGIC Foundation.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Supporting the goals and ideals of the MAGIC Foundation.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Preserving Access to Orphan Drugs Act of 2013
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: DLA PIPER LLP (US)
Orphan exemption to the annual pharmaceutical fee; Orphan drug tax credit; Patient access to therapies; H.R. 2315/S. 1128, Preserving Access to Orphan Drugs Act; H.R. 460, Patients Access to Treatments Act; H.R. 3116, Modernizing Our Drug and Diagnostics Evaluation and Regulatory Network Cures Act.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
H.R. 15/S. 744, Border Security, Economic Opportunity, and Immigration Modernization Act. H.R. 1772, Legal Workforce Act.
H.R. 15/S. 744, Border Security, Economic Opportunity, and Immigration Modernization Act. H.R. 1772, Legal Workforce Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Preventing Diabetes in Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
H.R. 15/S. 744, Border Security, Economic Opportunity, and Immigration Modernization Act. H.R. 1772, Legal Workforce Act.
H.R. 1851/S. 881, Family Act of 2013.
H.R. 1851/S. 881, Family Act of 2013.
H.R. 1851/S. 881, Family Act of 2013.
Safeguarding America's Pharmaceuticals Act of 2013
Client: EMD SERONO, INC. · Firm: DLA PIPER LLP (US)
S. 959, Pharmaceutical Quality, Security and Accountability Act. H.R. 1919, Safeguarding America's Pharmaceutical Act of 2013. H.R. 3204, the Drug Quality and Security Act.
Safeguarding America's Pharmaceuticals Act of 2013
Client: EMD SERONO, INC. · Firm: DLA PIPER LLP (US)
S. 959, Pharmaceutical Quality, Security and Accountability Act. H.R. 1919, Safeguarding America's Pharmaceutical Act of 2013.
Safeguarding America's Pharmaceuticals Act of 2013
Client: EMD SERONO, INC. · Firm: DLA PIPER LLP (US)
S. 959, Pharmaceutical Quality, Security and Accountability Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 3204, the Drug Quality and Security Act.
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: PFIZER, INC. · Firm: DLA PIPER LLP (US)
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; Implementation of Public Law No. 112-144, the Food and Drug Administration Safety and Innovation Act; FDA-related safety issues; H.R. 2725, Food and Drug Administration Safety Over Sequestion Act of 2013.
S. 959, Pharmaceutical Quality, Security and Accountability Act. H.R. 1919, Safeguarding America's Pharmaceutical Act of 2013. H.R. 3204, the Drug Quality and Security Act.
S. 959, Pharmaceutical Quality, Security and Accountability Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 3204, the Drug Quality and Security Act.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Supporting the goals and ideals of the MAGIC Foundation.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Medicare Better Health Rewards Program Act of 2013
Client: PFIZER, INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare/Medicaid reimbursements; S. 1228, Medicare Better Health Records Program Act of 2013.
Medicare Better Health Rewards Program Act of 2013
Client: PFIZER, INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare/Medicaid reimbursements; S. 1228, Medicare Better Health Records Program Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
H.R. 1851/S. 881, Family Act of 2013.
H.R. 1851/S. 881, Family Act of 2013.
H.R. 1851/S. 881, Family Act of 2013.
Pharmaceutical Quality, Security, and Accountability Act
Client: EMD SERONO, INC. · Firm: DLA PIPER LLP (US)
S. 959, Pharmaceutical Quality, Security and Accountability Act. H.R. 1919, Safeguarding America's Pharmaceutical Act of 2013. H.R. 3204, the Drug Quality and Security Act.
Pharmaceutical Quality, Security, and Accountability Act
Client: EMD SERONO, INC. · Firm: DLA PIPER LLP (US)
S. 959, Pharmaceutical Quality, Security and Accountability Act. H.R. 1919, Safeguarding America's Pharmaceutical Act of 2013.
Pharmaceutical Quality, Security, and Accountability Act
Client: EMD SERONO, INC. · Firm: DLA PIPER LLP (US)
S. 959, Pharmaceutical Quality, Security and Accountability Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 3204, the Drug Quality and Security Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
S. 744, Border Security, Economic Opportunity, and Immigration Modernization Act.
S. 744, Border Security, Economic Opportunity, and Immigration Modernization Act.
H.R. 15/S. 744, Border Security, Economic Opportunity, and Immigration Modernization Act. H.R. 1772, Legal Workforce Act.
Green Infrastructure for Clean Water Act of 2011
Client: PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION · Firm: DLA PIPER LLP (US)
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions; economic development and other tax issues; the American Jobs Act; H.R. 2030, the Puerto Rico Investment Promotion Act of 2011.
Green Infrastructure for Clean Water Act of 2011
Client: PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION · Firm: DLA PIPER LLP (US)
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions; economic development and other tax issues; U.S.-Spain international tax convention; the American Jobs Act; H.R. 2030, the Puerto Rico Investment Promotion Act of 2011.
Green Infrastructure for Clean Water Act of 2011
Client: PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION · Firm: DLA PIPER LLP (US)
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions; Economic development and other tax issues; U.S.-Spain international tax convention; the American Jobs Act; H.R. 2030, the Puerto Rico Investment Promotion Act of 2011.
H.R. 2164, Legal Workforce Act.
H.R. 2164, Legal Workforce Act.
Puerto Rico Investment Promotion Act of 2011
Client: PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION · Firm: DLA PIPER LLP (US)
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions; economic development and other tax issues; the American Jobs Act; H.R. 3020, the Puerto Rico Investment Promotion Act of 2011.
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
Counterfeit Drug Penalty Enhancement Act of 2012
Client: PFIZER, INC. · Firm: DLA PIPER LLP (US)
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; S. 3187, The Food and Drug Administration Safety and Innovation Act; H.R. 5651, The Food and Drug Administration Reform Act of 2012; H.R. 3668, The Counterfeit Drug Penalty Enhancement Act of 2012.
Counterfeit Drug Penalty Enhancement Act of 2012
Client: PFIZER, INC. · Firm: DLA PIPER LLP (US)
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; S. 3187, The Food and Drug Administration Safety and Innovation Act; H.R. 5651, The Food and Drug Administration Reform Act of 2012; H.R. 3668, The Counterfeit Drug Penalty Enhancement Act of 2012.
Food and Drug Administration Reform Act of 2012
Client: PFIZER, INC. · Firm: DLA PIPER LLP (US)
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; S. 3187, The Food and Drug Administration Safety and Innovation Act; H.R. 5651, The Food and Drug Administration Reform Act of 2012; FDA-related safety issues.
Food and Drug Administration Reform Act of 2012
Client: PFIZER, INC. · Firm: DLA PIPER LLP (US)
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; S. 3187, The Food and Drug Administration Safety and Innovation Act; H.R. 5651, The Food and Drug Administration Reform Act of 2012; H.R. 3668, The Counterfeit Drug Penalty Enhancement Act of 2012.
Food and Drug Administration Reform Act of 2012
Client: PFIZER, INC. · Firm: DLA PIPER LLP (US)
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; S. 3187, The Food and Drug Administration Safety and Innovation Act; H.R. 5651, The Food and Drug Administration Reform Act of 2012; H.R. 3668, The Counterfeit Drug Penalty Enhancement Act of 2012.
Sequester Replacement Reconciliation Act of 2012
Client: PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION · Firm: DLA PIPER LLP (US)
Implementation of Patient Protection and Affordable Care Act, provisions related to health IT; Medicaid funding, and exchange grants; Implementation of the American Recovery and Reinvestment Act of 2009, provisions related to health IT; Medicare Part B enrollment issues; H.R. 5652, Sequester Replacement Reconciliation Act of 2012, provisions related to Medicaid.
Sequester Replacement Reconciliation Act of 2012
Client: PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION · Firm: DLA PIPER LLP (US)
Implementation of Patient Protection and Affordable Care Act, provisions related to health IT; Medicaid funding, and exchange grants; Implementation of the American Recovery and Reinvestment Act of 2009, provisions related to health IT; Medicare Part B enrollment issues; H.R. 5652, Sequester Replacement Reconciliation Act of 2012, provisions related to Medicaid.
Sequester Replacement Reconciliation Act of 2012
Client: PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION · Firm: DLA PIPER LLP (US)
Implementation of Patient Protection and Affordable Care Act, provisions related to health IT; Medicaid funding, and exchange grants; Implementation of the American Recovery and Reinvestment Act of 2009, provisions related to health IT; Medicare Part B enrollment issues; H.R. 5652, Sequester Replacement Reconciliation Act of 2012, provisions related to Medicaid.
To extend the temporary suspension of duty on mixtures of indoxacarb and inert ingredients.
Client: EMD SERONO, INC. · Firm: DLA PIPER LLP (US)
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act.
Green Infrastructure for Clean Water Act of 2011
Client: PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION · Firm: DLA PIPER LLP (US)
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions; Economic development and other tax issues; U.S.-Spain international tax convention; the American Jobs Act; H.R. 2030, the Puerto Rico Investment Promotion Act of 2011.
Green Infrastructure for Clean Water Act of 2011
Client: PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION · Firm: DLA PIPER LLP (US)
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions; Economic development and other tax issues; U.S.-Spain international tax convention; the American Jobs Act; H.R. 2030, the Puerto Rico Investment Promotion Act of 2011.
H.R. 2164, Legal Workforce Act.
H.R. 2164, Legal Workforce Act.
H.R. 2164, Legal Workforce Act.
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
America's Affordable Health Choices Act of 2009
Client: PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION · Firm: DLA PIPER LLP (US)
H.R. 3200, America's Affordable Health Choices Act of 2009, provisions affecting Puerto Rico. S. 1679, Affordable Health Choices Act, provisions affecting Puerto Rico. H.R. 3962, Affordable Health Care for America Act.
Home Star Energy Retrofit Act of 2010
Client: PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION · Firm: DLA PIPER LLP (US)
H.R. 5019, Home Star Energy Retrofit Act of 2010.
Affordable Health Choices Act
Client: PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION · Firm: DLA PIPER LLP (US)
H.R. 3200, America's Affordable Health Choices Act of 2009, provisions affecting Puerto Rico. S. 1679, Affordable Health Choices Act, provisions affecting Puerto Rico. H.R. 3962, Affordable Health Care for America Act.
Death Tax Repeal Act of 2007
Client: PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION · Firm: DLA PIPER LLP (US)
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions; Economic development and other tax issues; H.R. 1586, Education and Medicaid Funding for States, provisions affecting Puerto Rico; H.R. 4853, Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010.
PFIZER, INC. via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
Issues related to Medicare/Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; prescription drug abuse.
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
H.R. 4800, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, issues related to plasma protein therapies.
Issues related to Orphan drug designation; 21st Century Cures Initiative; Issues related to drug discovery and development; International Plasma Protein Awareness Week.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
Health care financing.
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Health care financing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Issues related to Orphan drug designation; 21st Century Cures Initiative; Issues related to drug discovery and development; International Plasma Protein Awareness Week.
H.R. 4800, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, issues related to plasma protein therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; prescription drug abuse.
Issues related to Medicare/Medicaid reimbursements.
NOVO NORDISK INC. via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Orphan exemption to the annual pharmaceutical fee; Orphan drug tax credit; Patient access to therapies; H.R. 2315/S. 1128, Preserving Access to Orphan Drugs Act; H.R. 460, Patients Access to Treatments Act; H.R. 3116, Modernizing Our Drug and Diagnostics Evaluation and Regulatory Network Cures Act.
Medicare reimbursement relating to plasma protein therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Health care financing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Issues related to Medicare/Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; perscription drug abuse.
Filing targets: SENATE
ADP LLC via DLA PIPER LLP (US)
2014 · second_quarter · Q2
H.R. 15/S. 744, Border Security, Economic Opportunity, and Immigration Modernization Act. H.R. 1772, Legal Workforce Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via DLA PIPER LLP (US)
2014 · second_quarter · RR
Medicare reimbrusement relating to plasma protein therapies; Orphan exemption to the annual pharmaceutical fee; Orphan drug tax credit; patient access to therapies.
Medicare reimbrusement relating to plasma protein therapies; Orphan exemption to the annual pharmaceutical fee; Orphan drug tax credit; patient access to therapies.
NOVO NORDISK INC. via DLA PIPER LLP (US)
2014 · first_quarter · 1A
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: SENATE
ADP LLC via DLA PIPER LLP (US)
2014 · first_quarter · Q1
H.R. 15/S. 744, Border Security, Economic Opportunity, and Immigration Modernization Act. H.R. 1772, Legal Workforce Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; Implementation of Public Law No. 112-144, the Food and Drug Administration Safety and Innovation Act; Sequester of FDA user fees.
Issues related to Medicare/Medicaid reimbursements.
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Health care financing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
S. 959, Pharmaceutical Quality, Security and Accountability Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 3204, the Drug Quality and Security Act.
H.R. 1851/S. 881, Family Act of 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADP LLC via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
H.R. 15/S. 744, Border Security, Economic Opportunity, and Immigration Modernization Act. H.R. 1772, Legal Workforce Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; Implementation of Public Law No. 112-144, the Food and Drug Administration Safety and Innovation Act; Sequester of FDA user fees.
Issues related to Medicare/Medicaid reimbursements; S. 1228, Medicare Better Health Records Program Act of 2013.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2013 · third_quarter · Q3
S. 959, Pharmaceutical Quality, Security and Accountability Act. H.R. 1919, Safeguarding America's Pharmaceutical Act of 2013. H.R. 3204, the Drug Quality and Security Act.
H.R. 1851/S. 881, Family Act of 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; Implementation of Public Law No. 112-144, the Food and Drug Administration Safety and Innovation Act; FDA-related safety issues; H.R. 2725, Food and Drug Administration Safety Over Sequestion Act of 2013.
Issues related to Medicare/Medicaid reimbursements; S. 1228, Medicare Better Health Records Program Act of 2013.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ADP LLC via DLA PIPER LLP (US)
2013 · third_quarter · Q3
S. 744, Border Security, Economic Opportunity, and Immigration Modernization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; Implementation of Public Law No. 112-144, the Food and Drug Administration Safety and Innovation Act; FDA-related safety issues.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2013 · second_quarter · Q2
H.R. 1851/S. 881, Family Act of 2013.
S. 959, Pharmaceutical Quality, Security and Accountability Act. H.R. 1919, Safeguarding America's Pharmaceutical Act of 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADP LLC via DLA PIPER LLP (US)
2013 · second_quarter · Q2
S. 744, Border Security, Economic Opportunity, and Immigration Modernization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Issues related to supply chain safety.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; Implementation of Public Law No. 112-144, the Food and Drug Administration Safety and Innovation Act; FDA-related safety issues.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ADP LLC via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Immigration reform.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2012 · fourth_quarter · 4A
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2012 · fourth_quarter · Q4
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; S. 3187, The Food and Drug Administration Safety and Innovation Act; H.R. 5651, The Food and Drug Administration Reform Act of 2012; FDA-related safety issues.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION via DLA PIPER LLP (US)
2012 · fourth_quarter · 4T
Appropriations issues affecting Puerto Rico.
Implementation of Patient Protection and Affordable Care Act, provisions related to health IT; Medicaid funding, and exchange grants; Implementation of the American Recovery and Reinvestment Act of 2009, provisions related to health IT; Medicare Part B enrollment issues; H.R. 5652, Sequester Replacement Reconciliation Act of 2012, provisions related to Medicaid.
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions; economic development and other tax issues; the American Jobs Act; H.R. 3020, the Puerto Rico Investment Promotion Act of 2011.
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2012 · fourth_quarter · Q4
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2012 · fourth_quarter · Q4
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2012 · third_quarter · Q3
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2012 · third_quarter · Q3
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2012 · third_quarter · Q3
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; S. 3187, The Food and Drug Administration Safety and Innovation Act; H.R. 5651, The Food and Drug Administration Reform Act of 2012; H.R. 3668, The Counterfeit Drug Penalty Enhancement Act of 2012.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION via DLA PIPER LLP (US)
2012 · third_quarter · Q3
Implementation of Patient Protection and Affordable Care Act, provisions related to health IT; Medicaid funding, and exchange grants; Implementation of the American Recovery and Reinvestment Act of 2009, provisions related to health IT; Medicare Part B enrollment issues; H.R. 5652, Sequester Replacement Reconciliation Act of 2012, provisions related to Medicaid.
Appropriations issues affecting Puerto Rico.
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions; economic development and other tax issues; the American Jobs Act; H.R. 2030, the Puerto Rico Investment Promotion Act of 2011.
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; S. 3187, The Food and Drug Administration Safety and Innovation Act; H.R. 5651, The Food and Drug Administration Reform Act of 2012; H.R. 3668, The Counterfeit Drug Penalty Enhancement Act of 2012.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2012 · second_quarter · Q2
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act.
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Issues related to Medicare and Medicaid drug rebates.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Department of Justice activities in Puerto Rico.
Implementation of Patient Protection and Affordable Care Act, provisions related to health IT; Medicaid funding, and exchange grants; Implementation of the American Recovery and Reinvestment Act of 2009, provisions related to health IT; Medicare Part B enrollment issues; H.R. 5652, Sequester Replacement Reconciliation Act of 2012, provisions related to Medicaid.
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions; economic development and other tax issues; U.S.-Spain international tax convention; the American Jobs Act; H.R. 2030, the Puerto Rico Investment Promotion Act of 2011.
ADP LLC via DLA PIPER LLP (US)
2012 · second_quarter · Q2
H.R. 2164, Legal Workforce Act.
EMD SERONO, INC. via DLA PIPER LLP (US)
2012 · first_quarter · Q1
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Issues related to Medicare and Medicaid drug rebates.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ADP LLC via DLA PIPER LLP (US)
2012 · first_quarter · Q1
H.R. 2164, Legal Workforce Act.
Filing targets: HOUSE OF REPRESENTATIVES
PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions; Economic development and other tax issues; U.S.-Spain international tax convention; the American Jobs Act; H.R. 2030, the Puerto Rico Investment Promotion Act of 2011.
Department of Justice activities in Puerto Rico.
GSA purchasing programs.
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2011 · fourth_quarter · RR
Health care financing.
NOVO NORDISK INC. via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
Issues related to Medicare and Medicaid drug rebates.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ADP LLC via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
H.R. 2164, Legal Workforce Act.
Filing targets: HOUSE OF REPRESENTATIVES
EMD SERONO, INC. via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions; Economic development and other tax issues; U.S.-Spain international tax convention; the American Jobs Act; H.R. 2030, the Puerto Rico Investment Promotion Act of 2011.
Appropriations issues affecting Puerto Rico.
GSA purchasing programs.
DES MOINES UNIVERSITY via DLA PIPER LLP (US)
2011 · fourth_quarter · 4T
Implementation of the Patient Protection and Affordable Health Care Act; funding for AHEC; workforce issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2011 · third_quarter · Q3
S. 965, Family Act of 2011.
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DES MOINES UNIVERSITY via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Implementation of the Patient Protection and Affordable Health Care Act; funding for AHEC; workforce issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Issues related to Medicare and Medicaid drug rebates.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ADP LLC via DLA PIPER LLP (US)
2011 · third_quarter · Q3
H.R. 2164, Legal Workforce Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Implementation of Patient Protection and Affordable Care Act, provisions related to health IT; Medicaid funding, and exchange grants; Implementation of the American Recovery and Reinvestment Act of 2009, provisions related to health IT; Medicare Part B enrollment issues.
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions; Economic development and other tax issues; U.S.-Spain international tax convention; the American Jobs Act; H.R. 2030, the Puerto Rico Investment Promotion Act of 2011.
Appropriations issues affecting Puerto Rico.
EMD SERONO, INC. via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Issues related to Medicare/Medicaid reimbursements.
S. 965, Family Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions; Economic development and other tax issues; U.S.-Spain international tax convention.
Appropriations issues affecting Puerto Rico.
GSA purchasing programs.
DES MOINES UNIVERSITY via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Implementation of the Affordable Health Care Act; funding for AHEC; workforce issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2011 · second_quarter · RR
S. 965 - The Family Act of 2011
ADP LLC via DLA PIPER LLP (US)
2011 · second_quarter · Q2
H.R. 2164, Legal Workforce Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION via DLA PIPER LLP (US)
2011 · first_quarter · Q1
Implementation of Patient Protection and Affordable Care Act, provisions related to health IT; Medicaid funding, and exchange grants; Implementation of the American Recovery and Reinvestment Act of 2009, provisions related to health IT; Medicare Part B enrollment issues.
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions; Economic development and other tax issues; U.S.-Spain international tax convention.
Appropriations issues affecting Puerto Rico.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
DES MOINES UNIVERSITY via DLA PIPER LLP (US)
2011 · first_quarter · Q1
Implementation of the Affordable Health Care Act; funding for AHEC; workforce issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION via DLA PIPER LLP (US)
2010 · fourth_quarter · 4A
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions; Economic development and other tax issues; H.R. 1586, Education and Medicaid Funding for States, provisions affecting Puerto Rico; H.R. 4853, Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010.
H.R. 2499, Puerto Rico Democracy Act of 2009.
Implementation of Patient Protection and Affordable Care Act, provisions related to health IT; Implementation of the American Recovery and Reinvestment Act of 2009, provisions related to health IT.
PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION via DLA PIPER LLP (US)
2010 · fourth_quarter · Q4
H.R. 2499, Puerto Rico Democracy Act of 2009.
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions; Economic development and other tax issues; H.R. 1586, Education and Medicaid Funding for States, provisions affecting Puerto Rico; H.R. 4853, Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010.
Implementation of Patient Protection and Affordable Care Act, provisions related to health IT; Implementation of the American Recovery and Reinvestment Act of 2009, provisions related to health IT.
PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION via DLA PIPER LLP (US)
2010 · third_quarter · Q3
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions; H.R. 4213, American Workers, State and Business Relief Act of 2010, provisions regarding extensions of domestic production activities deduction and Foreign Assets Tax Compliance Act; Economic development and other tax issues; H.R. 1586, Education and Medicaid Funding for States, provisions affecting Puerto Rico.
Implementation of Patient Protection and Affordable Care Act, provisions related to health IT; Implementation of the American Recovery and Reinvestment Act of 2009, provisions related to health IT.
PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION via DLA PIPER LLP (US)
2010 · second_quarter · Q2
H.R. 4899, Supplemental Appropriations Act, 2010, provisions affecting Puerto Rico.
Implementation of health care reform bill, provisions affecting Puerto Rico.
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions. H.R. 4213, American Workers, State and Business Relief Act of 2010, provisions regarding extensions of domestic production activities deduction and Foreign Assets Tax Compliance Act. Economic development and other tax issues.
PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION via DLA PIPER LLP (US)
2010 · first_quarter · Q1
H.R. 2499, Puerto Rico Democracy Act of 2009.
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions. H.R. 4213, American Workers, State and Business Relief Act of 2010, provisions regarding extensions of domestic production activities deduction and Foreign Assets Tax Compliance Act. Economic development and other tax issues.
H.R. 3200, America's Affordable Health Choices Act of 2009, provisions affecting Puerto Rico. S. 1679, Affordable Health Choices Act, provisions affecting Puerto Rico. H.R. 3962, Affordable Health Care for America Act.
2010 · first_quarter · Q1
Issues affecting incentives for automobile purchase.
PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION via DLA PIPER LLP (US)
2009 · fourth_quarter · Q4
H.R. 3200, America's Affordable Health Choices Act of 2009, provisions affecting Puerto Rico. S. 1679, Affordable Health Choices Act, provisions affecting Puerto Rico.
H.R. 2499, Puerto Rico Democracy Act of 2009.
Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions. H.R. 4213, Tax Extenders Act of 2009, provisions regarding extensions of domestic production activities deduction and Foreign Assets Tax Compliance Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
2009 · fourth_quarter · Q4
Issues affecting incentives for automobile purchase.
PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION via DLA PIPER LLP (US)
2009 · third_quarter · Q3
H.R. 3200, America's Affordable Health Choices Act of 2009, provisions affecting Puerto Rico S. 1679, Affordable Health Choices Act, provisions affecting Puerto Rico.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
MARATHON ASSET MANAGEMENT INC via DLA PIPER LLP (US)
2009 · third_quarter · Q3
Matters relating to the Treasury Department's legacy security program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · third_quarter · Q3
Issues affecting incentives for automobile purchase.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · Q2
S. 247, Accelerated Retirement of Inefficient Vehicles Act of 2009; H.R. 520, Accelerated Retirement of Inefficient Vehicles Act of 2009; H.R. 1606, New Automobile Voucher Act of 2009; H.R. 1550, Consumer Assistance to Recycle and Save Act of 2009; H.R. 550, The Get America Moving Again Act of 2009; S. 1135, Drive America Forward Act of 2009; S. 1200, Short Term Accelerated Retirement of Inefficient Vehicles Act of 2009; H.R. 2751, Consumer Assistance to Recycle and Save Act; H.R. 2346, Making supplemental appropriations for the fiscal year ending September 30, 2009, and for other purposes (provision creating "cash for clunkers" voucher program); H.R. 2454, American Clean Energy and Security Act of 2009 (provision creating "cash for clunkers" voucher program); H.R. 2640, Consumer Assistance to Recycle and Save Act; and S.A. 1255, Drive America Forward Act of 2009, S.A. 1273, Automobile Voucher Program, and S.A. 1278, Short Term Accelerated Retirement of Inefficient Vehicles Act of 2009, all amendments to H.R. 1256, Family Smoking Prevention and Tobacco Control Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSTITUTIONAL CREDIT PARTNERS via DLA PIPER LLP (US)
2009 · second_quarter · Q2
Matters relating to the Treasury Department's legacy security program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARATHON ASSET MANAGEMENT INC via DLA PIPER LLP (US)
2009 · second_quarter · Q2
Matters relating to the Treasury Department's legacy security program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION via DLA PIPER LLP (US)
2009 · second_quarter · Q2
Draft health care proposals, provisions affecting Puerto Rico.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
2009 · first_quarter · Q1
H.R. 384, TARP Reform & Accountability Act of 2009, and implementation of TARP program.
S. 247, Accelerated Retirement of Inefficient Vehicles Act of 2009; H.R. 520, Accelerated Retirement of Inefficient Vehicles Act of 2009; H.R. 1606, New Automobile Voucher Act of 2009; H.R. 1550, Consumer Assistance to Recycle and Save Act of 2009; H.R. 550, The Get America Moving Again Act of 2009.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION via DLA PIPER LLP (US)
2009 · first_quarter · Q1
H.R. 1, American Recovery and Reinvestment Act of 2009, health care issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION via DLA PIPER LLP (US)
2009 · first_quarter · RR
Tax, appropriations/budget, and health care issues affecting Puerto Rico.
Tax, appropriations/budget, and health care issues affecting Puerto Rico.
Tax, appropriations/budget, and health care issues affecting Puerto Rico.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Appropriations issues affecting Puerto Rico.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Implementation of Patient Protection and Affordable Care Act, provisions related to health IT; Medicaid funding, and exchange grants; Implementation of the American Recovery and Reinvestment Act of 2009, provisions related to health IT; Medicare Part B enrollment issues.
Appropriations issues affecting Puerto Rico.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Implementation of Patient Protection and Affordable Care Act, provisions related to health IT; Medicaid funding, and exchange grants; Implementation of the American Recovery and Reinvestment Act of 2009, provisions related to health IT; Medicare Part B enrollment issues.
Department of Justice activities in Puerto Rico.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
GSA purchasing programs.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Implementation of Patient Protection and Affordable Care Act, provisions related to health IT; Medicaid funding, and exchange grants; Implementation of the American Recovery and Reinvestment Act of 2009, provisions related to health IT; Medicare Part B enrollment issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 2499, Puerto Rico Democracy Act of 2009.
H.R. 4899, Supplemental Appropriations Act, 2010, provisions affecting Puerto Rico.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 5019, Home Star Energy Retrofit Act of 2010.
H.R. 2499, Puerto Rico Democracy Act of 2009.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of